Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Phenolics for Age-Related Macular Degeneration
NCT05005884Phase 1Unknown
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in age-related macular degeneration (AMD) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Plasma CD-163 at 1 month. Status: unknown.
02
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT05005884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005884.